Written by HealthDay News
Updated on March 08, 2007
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Irritable Bowel Syndrome (IBS)
Women ages 18-65 are invited to participate in this study, which will evaluate an experimental drug in treating symptoms of irritable bowel syndrome. Qualified volunteers will be compensated upon study completion. Participants must have irritable bowel syndrome meeting ROME II criteria. Additional requirements may apply.
The research site is in Los Angeles, Calif.
This study seeks volunteers ages 18-65 with symptoms of anxiety. There are no overnight stays and health insurance is not necessary. Qualified participants will receive compensation for time and travel.
The research site is in Orlando, Fla.
This study will evaluate an investigational pneumococcal vaccine. To participate, you must be between ages 60 and 64, and complete three clinic visits. Compensation is available for time and travel.
The research site is in Pittsburgh, Penn.
Copyright 2007 Thomson CenterWatch. All rights reserved.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.